News Room

Investor Announcement

Annual Report Filed on Form 20-F with SEC

Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) has announced that it has filed its Annual Report on Form 20-F containing audited consolidated financial
statements for the year ended June 30, 2017 with the US Securities and Exchange Commission.
The annual report is available on the Prana website (www.pranabio.com). Shareholders may receive a hard copy of the annual report free of charge upon request.

Contacts:
Investor Relations
Rebecca Wilson
E: rwilson@buchanwe.com.au
Tp: +61 3 9866 4722